NewsRx

Search our medical news database

Napo Pharmaceuticals

Napo Pharmaceuticals provides information on its latest news and research developments

Published in Hospital Law Weekly, March 8th, 2007

Napo Pharmaceuticals provides information on its latest news and research developments.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Napo Pharmaceuticals.

Report 1: Napo Pharmaceuticals, Inc., which develops and commercializes proprietary pharmaceuticals globally in collaboration with local partners, announced that James Nash, 56, has joined the company as its chief operating officer (COO).

Nash has almost 30 years of experience with pharmaceutical and biotechnology companies including Chiron Corporation, Millenium Pharmaceuticals and Monsanto/Searle. Most recently, Nash...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook